Penn study looks at risks associated with hip dysplasia - DVM
  • SEARCH:
News Center
DVM Featuring Information from:

ADVERTISEMENT

Penn study looks at risks associated with hip dysplasia


DVM360 MAGAZINE


"We have to put aside the 'all or nothing' notion. There is a variable degree of susceptibility for the disease," he explains.

"If the dog has a DI above .3, the susceptibility of having hip dysplasia increases—but that doesn't mean it's a guarantee that the dog will develop the condition."

To achieve genetic control of CHD, researchers say, an accurate test must minimize false-negative diagnoses that mistakenly permit the breeding of dogs that carry genes coding for CHD. Particularly for a late-onset disease such as CHD, dogs remaining in the gene pool must not only be free of obvious signs of CHD at the time of evaluation (2 years for OFA) but ideally should not be susceptible to the osteoarthritis of CHD that occurs later in life.

"We don't want people to think that if the dog is at risk that it isn't breedable," Smith says. "But if we can tighten the gene pool and only breed dogs that are better than the average, it can make a difference."

The study was conducted by Smith, Michelle Y. Powers, Georga T. Karbe, Thomas P. Gregor, Pamela McKelvie, William T. N. Culp and Hilary H. Fordyce of the Department of Clinical Studies at Penn Vet. Culp is currently with the School of Veterinary Medicine at the University of California, Davis.

The study was funded by the University of Pennsylvania, the National Institutes of Health, The Seeing Eye Inc., the Morris Animal Foundation and Nestle Purina Co. The article was published in the Journal of the American Veterinary Medical Association.

Smith, who is the inventor, and the University of Pennsylvania, which holds the patent, have a financial interest in the PennHIP method.


ADVERTISEMENT

Source: DVM360 MAGAZINE,
Click here